Traumatic brain injury (TBI) is characterized by neuroinflammation and structural damage leading to symptoms and altered brain function. Biomarkers are useful in understanding neuroinflammation and correlations with TBI sequalae. The purpose of this paper is to identify and discuss biomarkers of neuroinflammation used to study TBI and its sequalae. A systematic review was conducted using PubMed, CINAHL, Embase, and Web of Science. A total of 350 articles met criteria; 70 used biomarkers. PRISMA criteria were used for Quality Assessment. Articles included reviews (n = 17), case-control (n = 25), cross-sectional (n = 25) studies, and randomized controlled trials (n = 3). Twenty-seven biomarkers were identified, including inflammasomes, cytokines, neuropeptides, complement complexes, miRNA and exosomes, and glial cell-specific proteins. Biomarkers aid in predicting morbidity and mortality and advance our understanding of neuroinflammation in TBI. This systematic review advances our understanding of the neuroinflammatory response to better enable nurses and clinicians to provide informed care of TBI patients.
AlbertV.SubramanianA.AgrawalD.BhoiS. K.PallaviP.MukhopadhayayA. K. (2017). RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients. BMC Research Notes, 10(139), 1–9.
2.
American Congress of Rehabilitation Medicine. (1993). Definition of mild traumatic brain injury. Journal of Head Trauma Rehabilitation, 8(3), 86–87.
3.
AtifH.HicksS. D. (2019). A review of microRNA biomarkers in traumatic brain injury. Journal of Experimental Neuroscience, 13, 1–12.
4.
BegumG.ReddyR.YakoubK. M.BelliA.DaviesD. J.Di PietroV. (2020). Differential expression of circulating inflammatory proteins following sport-related traumatic brain injury. International Journal of Molecular Sciences, 21(4), 1216.
5.
BishopP.RoccaD.HenleyJ. M. (2016). Ubiquitin C-terminal hydrolase L1 (UCH-L10: Structure, distribution and roles in brain function and dysfunction. Biochemical Journal, 473(16), 2453–2462.
6.
BlythB. J.BazarianJ. J. (2010). Traumatic alterations in consciousness: Traumatic brain injury. Emergency Medicine Clinics of North America, 28(3), 571–594.
7.
BodnarC.MorgantiJ.BachstetterA. (2018). Depression following a traumatic brain injury: Uncovering cytokine dysregulation as a pathogenic mechanism. Neural Regeneration Research, 13(10), 1693.
8.
BogoslovskyT.GillJ.JerominA.DavisC.Diaz-ArrastiaR. (2016). Fluid biomarkers of traumatic brain injury and intended context of use. Diagnostics, 6(37), 1–22.
9.
BohnertS.SeiffertA.TrellaS.BohnertM.DistelL.OndruschkaB.MonoranuC. M. (2020). TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination. International Journal of Legal Medicine, 134(6), 2167–2176.
10.
Bonneh-BarkayD.ZagadailovP.ZouH.NiyonkuruC.FigleyM.StarkeyA.WangG.BisselS. J.WileyC. A.WagnerA. K. (2010). YKL-40 expression in traumatic brain injury: An initial analysis. Journal of Neurotrauma, 27(7), 1215–1223.
11.
CarabiasC. S.Castaño-LeónA. M.Blanca NavarroB.PaneroI.EirizC.GómezP. A.EgeaJ.LagaresA. J. (2020). Serum Amyloid A1 as a potential intracranial and extracranial clinical severity biomarker in traumatic brain injury. Journal of Intensive Care Medicine, 35(11), 1180–1195.
12.
CarabiasC. S.GomezP. A.PaneroI.EirizC.Castaño-LeónA. M.EgeaJ.LagaresA. (2020). Chitinase-3-Like protein 1, serum amyloid A1, C-reactive protein, and procalcitonin are promising biomarkers for intracranial severity assessment of traumatic brain injury: Relationship with Glasgow Coma Scale and computed tomography. World Neurosurgery, 134, e120–e143.
13.
Centers for Disease Control and Prevention. (2019). Surveillance report of traumatic brain injury –Related emergency department visits, hospitalizations, and deaths: United States, 2014. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.
14.
ChengM. H.ChangS. F. (2017). Frailty as a risk factor for falls among community dwelling people: Evidence from a meta-analysis. Journal of Nursing Scholarship, 49(5), 529–536.
15.
ChiarettiA.AntonelliA.MastrangeloA.PezzottiP.TortoroloL.TosiF.GenoveseO. (2008). Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. Journal of Neurotrauma, 25, 225–234.
16.
ChiricoV.LacquanitiA.SalpietroV.ManafòC.CalabròM. P.BuemiM.ArrigoT.SalpietroC. (2014). High-mobility group box 1 (HMGB1) in childhood: From bench to bedside. European Journal of Pediatrics, 173(9), 1123–1136.
CleggA.YoungJ.IliffeS.RikkertM. O.RockwoodK. (2013). Frailty in elderly people. The Lancet, 381(9868), 752–762.
19.
CoronadoV. G.HaileyesusT.ChengT. A.BellJ. M.Haarbauer-KrupaJ.LionbargerM. R.Flores-HerreaJ.McGuireL. C.GilchristJ. (2015). Trends in sports and recreation-related traumatic brain injuries treated in U.S. emergency departments: The National Electronic Injury Surveillance System-All Injury Program (NEISS-AIP) 2001–2012. Journal of Head Trauma Rehabilitation, 30(3), 185–197.
20.
CristóvãoJ. S.GomesC. M. (2019). S100B proteins in Alzheimer’s disease. Frontiers in Neuroscience, 13, 463.
21.
CzeiterE.MondelloS.KovacsN.SandorJ.GabrielliA.SchmidK.TortellaF.WangK. K. W.HayesR. L.BarzoP.EzerE.DocziT.BukiA. (2012). Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. Journal of Neurotrauma, 29(9), 1770–1778.
22.
DadasA.WashingtonJ.Diaz-ArrastiaR.JanigroD. (2018). Biomarkers in traumatic brain injury (TBI): A review. Neuropsychiatric Disease and Treatment, 14, 2989–3000.
23.
DaneshvarD. H.RileyD. O.NowinskiC. J.McKeeA. C.SternR. A.CantuR. C. (2011). Long-term consequences: Effects on normal development profile after concussion. Physical Medicine and Rehabilitation Clinics of North America, 22(4), 663–700.
24.
DeshmaneS. L.KremlevS.AminiS.SawayaB. E. (2009). Monocyte chemoattractant protein-1 (MCP-1): An overview. Journal of Interferon and Cytokine Research, 29(6), 313–26.
25.
Di BattistaA. P.BuonoraJ. E.RhindS. G.HutchisonM. G.BakerA. J.RizoliS. B.Diaz-ArrstiaR.MuellerG. P. (2015). Blood biomarkers in moderate-to-severe traumatic brain injury: Potential utility of a multi-marker approach in characterizing outcome. Frontiers in Neurology, 6(110), 1–9.
26.
Di PietroV.PortoE.RagusaM.BarbagalloC.DaviesD.MorcioneM.LoganA.Di PietroC.PurrelloM.GreyM.HammondD.SawlaniV.BarbeyA. K.BelliA. (2018). Salivary microRNAs: Diagnostic markers of mild traumatic brain injury in contact-sport. Frontiers in Molecular Neuroscience, 11, 290.
27.
D’SouzaM. M.TrivediR.SinghK.GroverH.ChoudhuryA.KaurP.KumarP.TripathiR. P. (2015). Traumatic brain injury and the post-concussion syndrome: A diffusion tensor tractography study. Indian Journal of Radiology and Imaging, 25(4), 404–414.
28.
DurazzoT. C.MattsonN.WeinerM. W. (2014). Smoking and increased Alzheimer’s disease risk: A review of potential mechanisms. Alzheimer’s & Dementia, 10, S122–S145.
29.
EdalatfarM.PiriS. M.MehrabinejahM.MousaviM.MeknatkhahS.FattahiM.-R.KavyaniZ.HajighaderyA.KavehM.AryannejadA.GhafouriM.JamshidiE.RezwanifarM. M.Sharif-AlhoseiniM. (2021). Biofluid biomarkers in traumatic brain injury: A systematic scoping review. Neurocritical Care, 35, 559–572.
30.
GalvaniV.HartmanK. P.RuprehtR. R.NovakovicS.StabucB.OcvirkJ.MenartV.PorekarV. G.StalcA.RozmanP.SerbecV. C. (2000). Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population. Pflugers Archives, 440(5), R61–3.
31.
GayenM.BhomiaM.BalakathiresanN.Knollmann-RitschelB. (2020). Exosomal microRNAs released by activated astrocytes as potential neuroinflammatory biomarkers. International Journal of Molecular Sciences, 21(7), 2312.
32.
GhaiV.FallenS.BaxterD.ScherlerK.KimT.ZhouY.MeabonJ. S.LogsdonA. F.BanksW. A.SchindlerA. G.CookD. G.PeskindE. R.LeeI.WangK. (2020). Alterations in plasma microRNA and protein levels in war veterans with chronic mild traumatic brain injury. Journal of Neurotrauma, 37(12), 1418–1430.
33.
GillJ.LatourL.Diaz-ArrastiaR.MotamediV.TurtzoC.ShahimP.MondelloS.DeVotoC.VerasE.HanlonD.SongL.JerominA. (2018). Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI. Neurology, 91(15), 1385–1389.
34.
GillJ.MotamediV.OsierN.DellK.ArcurioL.CarrW.WalkerP.AhlersS.LoPrestiM.YarnellA. (2017). Moderate blast exposure results in increased IL-6 and TNF-α in peripheral blood. Brain, Behavior, and Immunity, 65, 90–94.
GopcevicA.Mazul-SunkoB.MaroutJ.SekulicA.AntoljakN.SiranovicM.IvanecZ.MargaritoniM.Bekavac-BeslinM.ZarkovicN. (2007). Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. Tohoku Journal of Experimental Medicine, 211(4), 387–393.
37.
GrahamR.RivaraF. P.FordM. A. (2014). Sports-related concussions in youth: Improving the science, changing the culture. National Academies Press.
38.
GrosseteteM.PhelpsJ.ArkoL.YonasH.RosenbergG. A. (2009). Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Neurosurgery, 65(4), 702–708.
39.
GuedesV. A.DevotoC.LeeteJ.SassD.AcottJ. D.MithaniS.GillJ. M. (2020). Extracellular vesicle proteins and microRNAs as biomarkers for traumatic brain injury. Frontiers in Neurology, 11(663), 1–18.
40.
Health Evidence. (2016). Helping public health use best evidence in practice since 2005: Quality assessment tool – Review articles. Author. https://www.healthevidence.org
41.
HelmyA.AntoniadesC. A.GuilfoyleM. R.CarpenterK. L. H.HutchinsonP. J. (2012). Principal component analysis of the cytokine and chemokine response to human traumatic brain injury. PLoS ONE, 7(6), e39677.
42.
HergenroederG. W.MooreA. N.McCoyJ. P.Jr.SamselL.WardN. H.IIICliftonG. L.DashP. K. (2010). Serum IL-6: A candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. Journal of Neuroinflammation, 7, 19.
43.
HierD. B.Obafemi-AjayiT.ThimganM. S.OlbrichtG. F.AziziS.AllenB.HadiB. A.WunschD. C. (2021). Blood biomarkers for mild traumatic brain injury: A selective review of unresolved issues. Biomarker Research, 9, 70.
44.
HilleredL.DahlinA. P.ClausenF.ChuJ.BergquistJ.HjortK.EnbladP.LewénA. (2014). Cerebral microdialysis for protein biomarker monitoring in the neurointensive care setting: A technical approach. Frontiers in Neurology, 5(245), 1–11.
45.
HuibregtseM. E.BazarianJ. J.ShultzS. R.KawataK. (2021). The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury. Neuroscience and Biobehavioral Reviews, 130, 433–447.
46.
IrreraN.RussoM.PallioG.BittoA.ManninoF.MinutoliL.AltavillaD.SquadritoF. (2020). The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury. International Journal of Molecular Sciences, 21(17), 6204.
47.
JohnsonV. E.StewartW.SmithD. H. (2014). Traumatic brain injury and amyloid-ß pathology: A link to Alzheimer’s disease?Nature Reviews Neuroscience, 11(5), 361–370.
48.
JonesD. P. (2006). Redefining oxidative stress. Antioxidant and Redox Signaling, 8(9–10), 1865–1879.
49.
KazakovaM. H.PavlovG. A.DichevV. D.SimitchievK. K.StefanovC. S.SarafianV. S. (2021). Relationship between YKL-40, neuron-specific enolase, tumor necrosis factor-alpha, interleukin-6, and clinical assessment scores in traumatic brain injury. Archives of Trauma Research, 10(1), 23–29.
50.
KorotkovA.PuhakkaN.GuptaS. D.VuokilaN.BroekaartD. W. M.AninkJ. J.HeiskanenM.KarttunenJ.van ScheppingenJ.HuitingaI.MillsJ. D.van VlietE. A.PitkänenA.AronicaE. (2020). Increased expression of miR142 and miR155 in glial and immune cells after traumatic brain injury may contribute to neuroinflammation via astrocyte activation. Brain Pathology, 30(5), 897–912.
51.
KumarR. G.DiamondM. L.BolesJ. A.BergerR. P.TishermanS. A.KochanekP. M.WagnerA. K. (2015). Acute CSF interleukin-6 trajectories after TBI: Associations with neuroinflammation, polytrauma, and outcome. Brain Behavior and Immunity, 45, 253–262.
52.
LaskowskiR. A.CreedJ. A.RaghupathiR. (2015). Pathophysiology of mild TBI: Implications for altered signaling pathways. In KobeissyF. H. (Ed.), Brain neurotrauma: Molecular, neuropsychological, and rehabilitation aspects. CRC Press/Taylor & Francis, Chapter 4.
53.
LeclercE.SturchlerE.VetterS. W. (2010). The S100B/RAGE axis in Alzheimer’s disease. Cardiovascular Psychiatry and Neurology, 2010, 539581.
54.
LenskiM.BiczokA.NeufischerK.TonnJ.BriegelJ.ThonN. (2019). Significance of cerebrospinal fluid inflammatory markers for diagnosing external ventricular drain -associated ventriculitis in patients with severe traumatic brain injury. Neurosurgical Focus, 47(5), 1–9.
55.
LeoP.McCreaM. (2016). Epidemiology. In LaskowitzD.GrantG. (Eds.), Translational research in traumatic brain injury. Taylor & Francis Group.
56.
LindbladC.PinE.JustD.NimerF. A.NilssonP.BellanderB. (2021). Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood -brain barrier disruption and outcome prediction following severe traumatic brain injury: A prospective, observational study. Critical Care, 25(1), 1–8.
57.
LorenteL. (2015). New prognostic biomarkers in patients with traumatic brain injury. Archives of Trauma Research, 4(4), e30165.
58.
LorenteL.MartinM. M.LopezP.RamosL.BlanquerJ.CaceresJ. J. (2014). Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe traumatic brain injury. PLoS ONE, 9(4), e94370.
59.
LorenteL.MartínM. M.Pérez-CejasA.González-RiveroA. F.ArguesoM.RamosL.Solé-ViolánJ.CáceresJ. J.JiménezA.García-MarínV. (2019). Persistently high serum substance P levels and early mortality in patients with severe traumatic brain injury. World of Neurosurgery, 132, e613–e617.
60.
MansourN. O.ShamaM. A.WeridaR. H. (2021). The effect of doxycycline on neuron-specific enolase in patients with traumatic brain injury: A randomized controlled trial. Therapeutic Advances in Chronic Disease, 12, 1–11.
61.
MarklundN.VedungF.LubberinkM.TegnerY.JohanssonJ.BlennowK.ZetterbergH.FahlströmM.HallerS.StensonS.LarssonE. M.WallA.AntoniG. (2021). Tau aggregation and increased neuroinflammation in athletes after sports -related concussions and in traumatic brain injury patients: A PET/MR study. Neuroimage Clinical, 30, 102665.
62.
MazzeoA. T.FilippiniC.RosatoR.FanelliV.AssenzioB.PiperI. (2016). Multivariate projection method to investigate inflammation associated with secondary insults and outcome after human traumatic brain injury: A pilot study. Journal of Neuroinflammation, 13(1), 157.
63.
McClincyM. P.LovellM. R.PardiniJ.CollinsM. W.SporeM. K. (2006). Recovery from sports concussion in high school and collegiate athletes. Brain Injury, 20(1), 33–39.
64.
McKeeA. C.RobinsonM. E. (2014). Military-related traumatic brain injury and neurodegeneration. Alzheimers Dementia, 10(3 Suppl), S242–S253.
65.
MendozaD. A.LópezK. D.EcheverriR. A.PastorL.RuedaS.FernándezL. L.MantillaD. S.DíazM. F.RamírezM. C.BarragánD. C.RubianoA. M. (2020). Utility of biomarkers in traumatic brain injury: A narrative review. Colombian Journal of Anesthesiology (Revista Colombiana de Anestesiología), 48(3), 155–161.
66.
MezJ.DaneshvarD. H.KiernanP. T.AbdolmohammadiB.AlvarezV. E.HuberB. R.AloscoM. L.SolomonT. M.NowinskiC. J.McHaleL.CormierK. A.KubilusC. A.MartinB. M.MurphyL.BaughC. M.MontenigroP. H.ChaissonC. E.TripodisY.KowallN. W.. . . McKeeA. C. (2017). Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. Journal of the American Medical Association, 318(4), 360–370.
67.
MishraS. K.Hemanth KumarB. S.KhushuS.SinghA. K.GangenahalliG. (2017). Early monitoring and quantitative evaluation of macrophage infiltration after experimental traumatic brain injury: A magnetic resonance imaging and flow cytometric analysis. Molecular and Cellular Neuroscience, 78, 25–34.
NeriM.FratiA.TruillazziE.CantatoreS.CipolloniL.Di PaoloM.FratiP.La RussaR.MaieseA.ScopettiM.SanturroA.SessaF.ZampareseR.FineschiV. (2018). Immunohistochemical evaluation of aquaporin-4 and its correlation with CD68, IBA-1, HIF-1α, GFAP, and CD15 expressions in fatal traumatic brain injury. International Journal of Molecular Science, 19(11), 3544.
70.
O’BrienW. T.PhamL.SymonsG. F.MonifM.ShultzS. R.McDonaldS. J. (2020). The NLRP3 inflammasome in traumatic brain injury: Potential as a biomarker and therapeutic target. Journal of Neuroinflammation, 17(1), 104.
71.
OliveraA.LejbmanN.JerominA.FrenchL. M.KimH.CashionA.MysliwiecV.Diaz-ArrastiaR.GillJ. (2015). Peripheral total tau in military personnel who sustain traumatic brain injuries during deployment. JAMA Neurology, 72(10), 1109–1116.
72.
OsierN.MotamediV.EdwardsK.PuccioA.Diaz-ArrastiaR.KennyK.GillJ. (2018). Exosomes in acquired neurological disorders: New insights into pathophysiology and treatment. Molecular Neurobiology, 55, 9280–9293.
73.
PanJ.GaoX.JiangH.LiY.XiaoF.ZhanR. (2015). Low serum ficolin-3 levels are associated with severity and poor outcome in traumatic brain injury. Journal of Neuroinflammation, 12, 226.
74.
ParryJ.HwangJ.StahelC. F.HendersonC.NadeauJ.StaceyS.BeauchampK.MooreE. E.StahelP. F. (2020). Soluble terminal complement activation fragment sC5b-9: A new serum biomarker for traumatic brain injury. European Journal of Trauma and Emergency Surgery, 47, 1491–1497.
75.
PaudelY. N.AngelopoulouE.PiperiC.OthmanI.ShaikhM. F. (2020). HMGB1-mediated neuroinflammatory responses in brain injuries: Potential mechanisms and therapeutic opportunities. International Journal of Molecular Sciences, 21, 4069.
76.
PengT. I.JouM. J. (2010). Oxidative stress caused by mitochondrial calcium overload. Annals of the New York Academy of Sciences, 1201, 183–188.
77.
PerryE.HowesM. J. R. (2011). Medicinal plants and dementia therapy: Herbal hopes for brain aging?CNS Neuroscience & Therapeutics, 17, 683–698.
78.
Pin-OnP.SaringkarinkulA.PunjasawadwongY.KachaS.WilairatD. (2018). Serum electrolyte imbalance and prognostic factors of postoperative death in adult traumatic brain injury patients: A prospective cohort study. Medicine, 97(45), e13081.
79.
RafiqM. F.AhmedN.KhanA. A. (2013). Serum electrolyte derangements in patients with traumatic brain injury. Journal of Ayub Medical Collection Abbottabad, 25, 162–164.
RhoneyD. H.ParkerD. (2006). Considerations in fluids and electrolytes after traumatic brain injury. Nutrition and Clinical Practice, 21, 462–478.
82.
RoeC.TverdalC.HoweE. I.TenovuoO.AzouviP.AndelicN. (2019). Randomized controlled trials of rehabilitation services in the post-acute phase of moderate and severe traumatic brain injury: A systematic review. Frontiers in Neurology, 10, 557.
83.
SandsmarkD. K.Diaz-ArrastiaR. (2021). Advances in traumatic brain injury research in 2020. The Lancet, Neurology, 20(1), 5–7.
84.
SatchellM. A.LaiY.KochanekP. M.WisniewskiS. R.FinkE. L.SiedbergN. A.BergerR. P.DeKoskyS. T.AdelsonP. D.ClarkR. S. B. (2005). Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse. Journal of Cerebral Blood Flow & Metabolism, 25, 919–927.
85.
SedgerL. M.McDermottM. F. (2014). TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants- past, present and future. Cytokine & Growth Factor Reviews, 25(4), 453–472.
86.
Sheikh-WuS. F.GerberK. S.PintoM. D.DownsC. A. (2022). Mechanisms and methods to understand depressive symptoms across populations. Issues in Mental Health Nursing43(5), 434–446.
87.
ShettyT.CogsilT.DalalA.KimE.HalvorsenK.CummingsK.NguyenJ. T. (2019). Retrospective study of potential blood biomarker of inflammation in acute mild traumatic brain injury. Journal of Head Trauma Rehabilitation, 34(3), E28–E36.
88.
SinghK.TrivediR.DeviM. M.TripathiR. P.KhushuS. (2016). Longitudinal changes in the DTI measures, anti-GFAP expression and levels of serum inflammatory cytokines following mild traumatic brain injury. Experimental Neurology, 275(3), 427–435.
89.
SteinD. M.LindellA. L.MurdockK. R.KuferaJ. A.MenakerJ.KeledijanK.BochicchioG. V.AarabiB.ScaleaT. M. (2011). Relationship of serum and cerebrospinal fluid biomarkers with intracranial hypertension and cerebral hypoperfusion after severe traumatic brain injury. The Journal of Trauma Injury, Infection, and Critical Care, 70(5), 1096–1103.
90.
StrimbuK.TavelJ. A. (2010). What are biomarkers?Current Opinions in HIV/AIDS, 5(6), 463–466.
91.
SumanS.KumarN.SinghY.KumarV.YadavG.GuptaB. K.PandeyA. R.PandeyS. (2016). Evaluation of serum electrolytes in traumatic brain injury patients: A prospective randomized observational study. Journal of Anesthesia and Critical Care, 5, 00184.
92.
TaylorC. A.BellJ. M.BreidingM. J.XuL. (2017). Traumatic brain injury-related emergency department visits, hospitalizations, and deaths: United States, 2007 and 2013. Morbidity and Mortality Weekly Report, 66(9), 1–16.
93.
TeasdaleG.JennettB. (1974). Assessment of coma and impaired consciousness: A practical scale. The Lancet, 2(7872), 81–84.
94.
TerrioH.BrennerL. A.IvinsB. J.ChoJ. M.HelmickK.SchwabK. (2009). Traumatic brain injury screening: Preliminary findings in a U.S. army brigade combat team. Journal of Head Trauma Rehabilitation, 24(1), 14–23.
95.
ThompsonH. J.MarthaS. R.WangJ.BeckerK. J. (2020). Impact of age on plasma inflammatory biomarkers in the 6 months following mild traumatic brain injury. Journal of Head Trauma Rehabilitation, 35(5), 324–331.
96.
TomanE.HarrissonS.BelliT. (2016). Biomarkers in traumatic brain injury: A review. BMJ Military Health, 162(2), 103–108.
97.
VajtrD.BenadaO.KukackaJ.PrusaR.HoustavaL.ToupalikP.KizekR. (2009). Correlation of ultrastructural changes of endothelial cells and astrocytes occurring during blood brain barrier damage after traumatic brain injury with biochemical markers of BBB leakage and inflammatory response. Physiological Research/Academia Scientiarum Bohemoslovaca, 58(2), 263–268.
98.
ValeraE. M.CaoA.PasternakO.ShentonM. E.KubickiM.MakrisN.AdraN. (2019). White matter correlates of mild traumatic brain injuries in women subjected to intimate partner violence: A preliminary study. Journal of Neurotrauma, 36(5), 661–668.
99.
VijapurS. M.VaughanL. E.AwanN.DiSantoD.McKernanG. P.WagnerA. K. (2021). Treelet transform analysis to identify clusters of systemic inflammatory variance in a population with moderate-to-severe traumatic brain injury. Brain Behavior and Immunity, 95, 45–60.
100.
VisserK.KoggelM.BlaauwJ.van der HornH. J.JacobsB.van der NaaltJ. (2022). Blood-based biomarkers of inflammation in mild traumatic brain injury: A systematic review. Neuroscience and Biobehavioral Reviews, 132, 154–168.
101.
VuokilaN.AronicaE.KorotkovA.van VlietE. A.NuzhatS.PuhakkaN.PitkänenA. (2020). Chronic regulation of miR-124-3p in the perilesional cortex after experimental and human TBI. International Journal of Molecular Sciences, 21, 2418.
102.
WallischJ. S.SimonD. W.BayirH.BellM. J.KochanekP. M.ClarkR. S. B. (2017). Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children. Neurocritical Care, 27(1), 44–50.
103.
WeberD. J.AlletteY. M.WilkesD. S.WhiteF. A. (2015). The HMGB1-RAGE inflammatory pathway: Implications for brain injury-induced pulmonary dysfunction. Antioxidants & Redox Signaling, 23(17), 1316–1328.
104.
WongA. D.YeM.LevyA. F.RothsteinJ. D.BerglesD. E.SearsonP. C. (2013). The blood-brain barrier: An engineering perspective. Frontiers in Neuroengineering, 6(7), 1–22.
105.
YanE. B.SatgunaseelanL.PaulE.ByeN.NguyenP.AgyapomaaD.KossmannT.RosenfeldJ. V.Morganti-KossmannM. C. (2014). Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury. Journal of Neurotrauma, 31(7), 618–629.
106.
YanS. F.RamasamyR.SchimdtA. M. (2010). The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature. Circulation Research, 106(5), 842–853.
107.
YarlagaddaA.AlfsonE.ClaytonA. H. (2009). The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry, 6(11), 18–22.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
